Next Gen Diagnostics CEO Paul A. Rhodes Announces Formation of Subsidiary NGD Israel, Ltd.
Tel Aviv, Israel (PRWEB) January 09, 2023 -- Next Gen Diagnostics CEO Paul Rhodes Announces Formation of Israeli Subsidiary, NGD Israel, Ltd.January 9, 2023
Stay updated with breaking news from Gen Diagnostics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Tel Aviv, Israel (PRWEB) January 09, 2023 -- Next Gen Diagnostics CEO Paul Rhodes Announces Formation of Israeli Subsidiary, NGD Israel, Ltd.January 9, 2023
West Palm Beach, Florida (PRWEB) September 27, 2022 -- Next Gen Diagnostics Announces that Cleveland Clinical Microbiology Lab Medical Director Daniel Rhoads
West Palm Beach, Florida (PRWEB) September 22, 2022 -- Next Gen Diagnostics Announces that Romney Humphries has Joined its Scientific Advisory BoardSeptember
MicroGenDX is Introducing PerioDX, the First Commercially Available Saliva-Based qPCR+NGS Test for Oral Health Share Article PerioDX is the first commercially available saliva-based periodontal test for comprehensive DNA diagnostic results. PerioDX can also aid clinicians in addressing concerns about potential links between the oral microbiome and systemic diseases. ORLANDO, Fla. (PRWEB) May 24, 2021 MicroGen Diagnostics, the industry leader in providing next-generation DNA sequencing (NGS) for clinical diagnostics, announces its...